Literature DB >> 29457739

Scutellarein from Scutellaria barbata induces apoptosis of human colon cancer HCT116 cells through the ROS-mediated mitochondria-dependent pathway.

Fei Guo1, Feng Yang2, Yan-Hong Zhu3.   

Abstract

To search novel therapy for human colon cancer, scutellarein identified from Scutellaria barbata was investigated using HCT116 cells. As a result, scutellarein can induce apoptosis of HCT116 cells. Further investigation for the mechanism has revealed scutellarein can increase the production of intracellular ROS and lead to the collapse of mitochondrial membrane potential. Meanwhile, the activity of caspase-3 in HCT116 cells was elevated by scutellarein. Moreover, down-regulated Bcl-2 and up-regulated Bax were observed. Additionaly, scutellarein resulted in cytochrome c release from mitochondria. These results indicated the apoptosis induction of HCT116 cells by scutellarein was implemented through ROS-mediated mitochondria-dependent pathway.

Entities:  

Keywords:  HCT116 cell; ROS; apoptosis; mitochondria-dependent pathway; scutellarein

Mesh:

Substances:

Year:  2018        PMID: 29457739     DOI: 10.1080/14786419.2018.1440230

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  2 in total

1.  Molecular Assessment of Scutellaria barbata D. Don in the Treatment of Nasopharyngeal Carcinoma Based on Network Pharmacology and Experimental Verification.

Authors:  Hongjian Shi; Jie Liu; Jingying Fan; Lan He; Xianwen Wang; Faqing Tang; Daofa Tian; Yingchun He
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-07       Impact factor: 2.629

2.  Bruceine D Identified as a Drug Candidate against Breast Cancer by a Novel Drug Selection Pipeline and Cell Viability Assay.

Authors:  Claudia Cipriani; Maria Pires Pacheco; Ali Kishk; Maryem Wachich; Daniel Abankwa; Elisabeth Schaffner-Reckinger; Thomas Sauter
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.